Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Natural compounds fromClerodendrumspp. as possible therapeutic candidates against SARS-CoV-2: Anin silicoinvestigation
Pallab Kar, Neeta Raj Sharma, Bhupender Singh, et al.
Journal of Biomolecular Structure and Dynamics (2020) Vol. 39, Iss. 13, pp. 4774-4785
Open Access | Times Cited: 76

Showing 26-50 of 76 citing articles:

Discovering new potential inhibitors to SARS-CoV-2 RNA dependent RNA polymerase (RdRp) using high throughput virtual screening and molecular dynamics simulations
Dylan Brunt, Phillip M. Lakernick, Chun Wu
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 14
The Biosynthesis and Medicinal Properties of Taraxerol
Ahmad Asnawi Mus, Lucky Poh Wah Goh, Hartinie Marbawi, et al.
Biomedicines (2022) Vol. 10, Iss. 4, pp. 807-807
Open Access | Times Cited: 13
Therapeutic mechanism of Toujie Quwen granules in COVID-19 based on network pharmacology
Ying Huang, Wenjiang Zheng, Yongshi Ni, et al.
BioData Mining (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 20
Insilicoinquest reveals the efficacy of Cannabis in the treatment of post-Covid-19 related neurodegeneration
Indrani Sarkar, Gargi Sen, Malay Bhattacharya, et al.
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 17, pp. 8030-8039
Closed Access | Times Cited: 17
Structural Insight into the Binding of Cyanovirin-N with the Spike Glycoprotein, Mpro and PLpro of SARS-CoV-2: Protein–Protein Interactions, Dynamics Simulations and Free Energy Calculations
Devashan Naidoo, Pallab Kar, Ayan Roy, et al.
Molecules (2021) Vol. 26, Iss. 17, pp. 5114-5114
Open Access | Times Cited: 17
Screening of potent phytochemical inhibitors against SARS-CoV-2 protease and its two Asian mutants
Ijaz Muhammad, Noor Rahman, Gul-E-Nayab, et al.
Computers in Biology and Medicine (2021) Vol. 133, pp. 104362-104362
Open Access | Times Cited: 16
Inhibition of the predicted allosteric site of the SARS-CoV-2 main protease through flavonoids
Bibi Kubra, Syed Badshah, Shah Faisal, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 18, pp. 9103-9120
Closed Access | Times Cited: 10
Insights from computational studies on the potential of natural compounds as inhibitors against SARS-CoV-2 spike omicron variant
Abdulrahim A. Alzain
SAR and QSAR in environmental research (2022) Vol. 33, Iss. 12, pp. 953-968
Closed Access | Times Cited: 9
Screening of Natural Products Targeting SARS-CoV-2–ACE2 Receptor Interface – A MixMD Based HTVS Pipeline
K. Gopinath, Elmeri M. Jokinen, Sami T. Kurkinen, et al.
Frontiers in Chemistry (2020) Vol. 8
Open Access | Times Cited: 14
Multifaceted roles of plant derived small molecule inhibitors on replication cycle of SARS-CoV-2
B. Uma Reddy, Nanda Kishore Routhu, Anuj Kumar
Microbial Pathogenesis (2022) Vol. 168, pp. 105512-105512
Open Access | Times Cited: 8
A review on molecular docking analysis of phytocompounds against SARS-CoV-2 druggable targets
Abdullahi Temitope Jamiu, Carolina H. Pohl, Sharafa A Bello, et al.
All Life (2021) Vol. 14, Iss. 1, pp. 1100-1128
Open Access | Times Cited: 11
In silico investigations of the multi‐targeted antiviral potential of small molecule phytochemicals of Nelumbo nucifera Gaertn. seed extracts against SARS‐CoV‐2 for therapeutics of COVID‐19
Saya Tyagi, Anuradha Shukla, Heera Ram, et al.
Food Frontiers (2023) Vol. 4, Iss. 1, pp. 368-393
Open Access | Times Cited: 4
The Potential of Usnic-Acid-Based Thiazolo-Thiophenes as Inhibitors of the Main Protease of SARS-CoV-2 Viruses
Оlga I. Yarovaya, Aleksandr S. Filimonov, Dmitry S. Baev, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 215-215
Open Access | Times Cited: 1
Facing COVID-19 via anti-inflammatory mechanism of action: Molecular docking and Pharmacokinetic studies of six anti-inflammatory compounds derived from Passiflora edulis
Aristote Matondo, Jason T. Kilembe, Domaine T. Mwanangombo, et al.
Research Square (Research Square) (2020)
Closed Access | Times Cited: 10
Natural Products from Red Algal Genus Laurencia as Potential Inhibitors of RdRp and nsp15 Enzymes of SARS-CoV-2: An In Silico Perspective
Omkar Pokharkar, Harshavardhan Anumolu, Grigory V. Zyryanov, et al.
Microbiology Research (2023) Vol. 14, Iss. 3, pp. 1020-1048
Open Access | Times Cited: 3
SARS-CoV-2 main protease inhibitors from the stem barks of Discoglypremna caloneura (Pax) Prain (Euphorbiaceae) and Pterocarpus erinaceus Poir (Fabaceae) and their molecular docking investigation
Paul Toukam Djouonzo, Md Sofequl Islam Mukim, Pamela Kemda Nangmo, et al.
Applied Biological Chemistry (2023) Vol. 66, Iss. 1
Open Access | Times Cited: 3
A natural derivative from ethnomedicinal mushroom potentiates apoptosis, autophagy and attenuates cell migration, via fine tuning the Akt signaling in human lung adenocarcinoma cells (A549)
Sudeshna Nandi, Priyanka Upadhyay, Ayan Roy, et al.
Environmental Toxicology (2021) Vol. 37, Iss. 1, pp. 52-68
Closed Access | Times Cited: 7
Comprehensive In silico Investigation Validates Two Flavonoid Compounds of Derris robusta (Roxb. ex DC.) Benth. to Supplant Remdesivir as Natural Therapeutic Remedy Against a Range of Coronaviruses
Arındam Ghosh, Sourav Chakraborty, Soumya Majumder, et al.
Letters in Applied NanoBioScience (2022) Vol. 12, Iss. 4, pp. 108-108
Open Access | Times Cited: 5
Identification of a promising inhibitor from Illicium verum (star anise) against the main protease of SARS-CoV-2: insights from the computational study
Manish Tripathi, Pushpendra Singh, Mukesh Kumar, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 14, pp. 6866-6882
Closed Access | Times Cited: 4
Discovery of pharmacological agents for triple-negative breast cancer (TNBC): molecular docking and molecular dynamic simulation studies on 5-lipoxygenase (5-LOX) and nuclear factor kappa B (NF-κB)
Sudipto Kundu, N Swathi, Durai Ananda Kumar T
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 17, pp. 9076-9089
Closed Access | Times Cited: 2
Drummondin E and Flinderole B are potential inhibitors of RNA-dependent RNA polymerase of SARS-CoV-2: an in silico study
Nahid Akhtar, Himanshu Verma, O.M. Silkari, et al.
BioTechnologia (2022) Vol. 103, Iss. 1, pp. 53-70
Open Access | Times Cited: 4
Facing COVID-19 Via Anti-Inflammatory Mechanism of Action: Molecular Docking and Pharmacokinetic Studies of Six Anti-Inflammatory Compounds Derived from Passiflora edulis
Aristote Matondo, Jason T. Kilembe, Domaine T. Mwanangombo, et al.
Journal of Complementary and Alternative Medical Research (2021), pp. 35-51
Open Access | Times Cited: 5
Factors for COVID-19 Infection that Govern the Severity of Illness
Bidisha Ghosh, Soumyadev Sarkar, Nayim Sepay, et al.
SciMedicine Journal (2021) Vol. 3, Iss. 2, pp. 177-197
Open Access | Times Cited: 5
Dissecting the Drug Development Strategies Against SARS-CoV-2 Through Diverse Computational Modeling Techniques
Nilanjan Adhikari, Sk. Abdul Amin, Tarun Jha
Methods in pharmacology and toxicology (2020), pp. 329-431
Closed Access | Times Cited: 4
WITHDRAWN: HPLC, GC–MS and FT-IR analysis of bioactive phytochemicals present in aqueous extract of leaf of Clerodendrum phlomidis: A further evidence for its medicinal diversity
M. Naveen, R. Kavitha
Materials Today Proceedings (2021)
Closed Access | Times Cited: 4

Scroll to top